Correlation Between Apple and Sinopharm Group

Can any of the company-specific risk be diversified away by investing in both Apple and Sinopharm Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apple and Sinopharm Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apple Inc and Sinopharm Group Co, you can compare the effects of market volatilities on Apple and Sinopharm Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apple with a short position of Sinopharm Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apple and Sinopharm Group.

Diversification Opportunities for Apple and Sinopharm Group

0.86

Correlation Coefficient

Apple  Sinopharm Group

Very poor diversification

The 3 months correlation between Apple and Sinopharm is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Apple Inc and Sinopharm Group Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinopharm Group and Apple is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apple Inc are associated (or correlated) with Sinopharm Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinopharm Group has no effect on the direction of Apple i.e., Apple and Sinopharm Group go up and down completely randomly.

Pair Corralation between Apple and Sinopharm Group

Assuming the 90 days trading horizon Apple Inc is expected to under-perform the Sinopharm Group. In addition to that, Apple is 1.1 times more volatile than Sinopharm Group Co. It trades about 0.0 of its total potential returns per unit of risk. Sinopharm Group Co is currently generating about 0.05 per unit of volatility. If you would invest  243.00  in Sinopharm Group Co on October 24, 2024 and sell it today you would earn a total of  8.00  from holding Sinopharm Group Co or generate 3.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Apple Inc  vs.  Sinopharm Group Co

Apple Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apple Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Apple is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Sinopharm Group

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sinopharm Group Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Sinopharm Group is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Apple and Sinopharm Group

The main advantage of trading using opposite Apple and Sinopharm Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apple position performs unexpectedly, Sinopharm Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinopharm Group will offset losses from the drop in Sinopharm Group's long position.

The idea behind Apple Inc and Sinopharm Group Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.